vimarsana.com
Home
Live Updates
Federal Circuit Reverses Novartis Gilyena Negative Limitatio
Federal Circuit Reverses Novartis Gilyena Negative Limitatio
Federal Circuit Reverses Novartis Gilyena Negative Limitation Decision - Patent
On June 21, 2022, the Federal Circuit acting on a request for panel rehearing in the decision by the Federal Circuit in Novartis v. Accord Health Care, Inc., 21 F.4th 1362 (Fed. Cir. 2022), affirming...
Related Keywords
Jordan ,
,
Intel Corp ,
Accord Health Care Inc ,
Memorandum Opinion In Health Discovery Corp ,
Novartis ,
Federal Circuit ,
Health Care ,
Judge Linn ,
Judgeo Malley ,
Judge Hughes ,
Chief Judge Moore ,
Judge Albright ,
Memorandum Opinion ,
Health Discovery ,
Circuit Judge Kent Jordan ,
Judges Moore ,
Circuit Judge Kent ,
Judgeso Malley ,
Judges Jordan ,
Mondaq ,
Federal Circuit Reverses Novartis Gilyena Negative Limitation Decision ,
Intellectual Property ,
Patent ,